Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 9:45 pm Purchase | 2025-12-31 | 13G | GeoVax Labs, Inc. GOVX | Armistice Capital, LLC | 2,675,610 8.260% | 2,611,101 (+4047.64%) | Filing History |
| 2026-02-17 08:00 am Purchase | 2025-12-31 | 13G | GeoVax Labs, Inc. GOVX | L1 Capital Global Opportunities Master Fund, Ltd. | 547,715 1.790% | 547,715 (New Position) | Filing History |
| 2026-02-13 4:41 pm Purchase | 2025-12-31 | 13G | GeoVax Labs, Inc. GOVX | Mitchell P. Kopin | 4,806,174 9.990% | 4,692,200 (+4116.91%) | Filing History |
| 2026-02-11 10:05 am Purchase | 2025-12-31 | 13G | GeoVax Labs, Inc. GOVX | Ayrton Capital LLC | 4,810,451 9.990% | 4,810,451 (New Position) | Filing History |
| 2025-11-07 5:24 pm Purchase | 2025-09-30 | 13G | GeoVax Labs, Inc. GOVX | Mitchell P. Kopin | 113,974 9.990% | 2,278 (+2.04%) | Filing History |
| 2025-08-14 9:18 pm Purchase | 2025-06-30 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Armistice Capital, LLC | 2,675,610 9.540% | 2,675,610 (New Position) | Filing History |
| 2025-07-08 5:02 pm Purchase | 2025-07-01 | 13G | GeoVax Labs, Inc. GOVX | Mitchell P. Kopin | 111,696 9.990% | 111,696 (New Position) | Filing History |
| 2025-07-07 4:30 pm Purchase | 2025-07-02 | 13G | GeoVax Labs, Inc. GOVX | L1 Capital Global Opportunities Master Fund, Ltd. | 59,000 5.860% | 59,000 (New Position) | Filing History |
| 2025-05-15 3:15 pm Purchase | 2025-03-31 | 13G | GeoVax Labs, Inc. GOVX | Armistice Capital, LLC | 64,509 9.990% | 44,686 (+225.42%) | Filing History |
| 2025-02-14 5:35 pm Sale | 2024-12-31 | 13G | GeoVax Labs, Inc. GOVX | Armistice Capital, LLC | 19,824 4.990% | -18,022 (-47.62%) | Filing History |
| 2024-11-14 5:10 pm Sale | 2024-09-30 | 13G | GeoVax Labs, Inc. GOVX | Armistice Capital, LLC | 37,845 9.990% | -86,597 (-69.59%) | Filing History |
| 2024-02-14 3:38 pm Purchase | 2023-12-31 | 13G | GeoVax Labs, Inc. GOVX | Armistice Capital, LLC | 124,443 9.990% | 124,443 (New Position) | Filing History |
| 2022-02-11 5:48 pm Sale | 2021-12-31 | 13G | GeoVax Labs, Inc. GOVX | L1 Capital Global Opportunities Master Fund, Ltd. | 0 0.000% | -1,024 (Position Closed) | Filing History |
| 2022-01-04 9:21 pm Sale | 2021-12-31 | 13G | GeoVax Labs, Inc. GOVX | SABBY MANAGEMENT LLC | 0 0.000% | -1,006 (Position Closed) | Filing History |